{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:59:09Z","timestamp":1791953949576,"version":"4.3.4"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.intimp.2024.112888","type":"journal-article","created":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T04:53:17Z","timestamp":1723351997000},"page":"112888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Neutrophils as promising therapeutic targets in pancreatic cancer liver metastasis"],"prefix":"10.1016","volume":"140","author":[{"given":"Minjie","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.intimp.2024.112888_b0005","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/cncr.33476","article-title":"The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"127","author":"Ouyang","year":"2021","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PPO.0000000000000290","article-title":"Diagnosis and detection of pancreatic cancer","volume":"23","author":"Chu","year":"2017","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.intimp.2024.112888_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102180","article-title":"Treatment landscape of metastatic pancreatic cancer","volume":"96","author":"De Dosso","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"43","key":"10.1016\/j.intimp.2024.112888_b0025","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112888_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230060","article-title":"The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies","volume":"15","author":"Us\u00f3n","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/genes11010006","article-title":"Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies","volume":"11","author":"Ayres Pereira","year":"2019","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0040","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic cancer: a review of current treatment and novel therapies","volume":"36","author":"Kolbeinsson","year":"2023","journal-title":"J. Invest. Surg."},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0045","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1152\/physrev.00012.2018","article-title":"The neutrophil\u2019s role during health and disease","volume":"99","author":"Liew","year":"2019","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2024.112888_b0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2016.12.012","article-title":"Neutrophils in homeostasis, immunity, and cancer","volume":"46","author":"Nicol\u00e1s-\u00c1vila","year":"2017","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0060","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00432-015-2024-0","article-title":"Process of hepatic metastasis from pancreatic cancer: biology with clinical significance","volume":"142","author":"Shi","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112888_b0065","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.3390\/cancers14123028","article-title":"The liver pre-metastatic niche in pancreatic cancer: a potential opportunity for intervention","volume":"14","author":"Gumberger","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41416-019-0479-5","article-title":"Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features","volume":"121","author":"Karamitopoulou","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0075","doi-asserted-by":"crossref","first-page":"aaf8943","DOI":"10.1126\/sciimmunol.aaf8943","article-title":"Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients","volume":"1","author":"Condamine","year":"2016","journal-title":"Sci. Immunol."},{"issue":"6367","key":"10.1016\/j.intimp.2024.112888_b0080","doi-asserted-by":"crossref","first-page":"eaal5081","DOI":"10.1126\/science.aal5081","article-title":"Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils","volume":"358","author":"Engblom","year":"2017","journal-title":"Science"},{"issue":"7754","key":"10.1016\/j.intimp.2024.112888_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","article-title":"Fatty acid transport protein 2 reprograms neutrophils in cancer","volume":"569","author":"Veglia","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2024.112888_b0090","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.112888_b0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-\u03b2: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.intimp.2024.112888_b0100","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1172\/JCI41649","article-title":"CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow","volume":"120","author":"Eash","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.intimp.2024.112888_b0105","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1158\/2326-6066.CIR-16-0188","article-title":"CXCR2-dependent accumulation of tumor-associated neutrophils regulates T-cell immunity in pancreatic ductal adenocarcinoma","volume":"4","author":"Chao","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"17","key":"10.1016\/j.intimp.2024.112888_b0110","doi-asserted-by":"crossref","first-page":"e146133","DOI":"10.1172\/jci.insight.146133","article-title":"DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis","volume":"6","author":"Deng","year":"2021","journal-title":"JCI Insight."},{"issue":"4","key":"10.1016\/j.intimp.2024.112888_b0115","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/bjc.2013.32","article-title":"Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer","volume":"108","author":"Ino","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0120","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/gutjnl-2021-326070","article-title":"Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment","volume":"72","author":"Wang","year":"2023","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","article-title":"The enhancement of glycolysis regulates pancreatic cancer metastasis","volume":"77","author":"Yang","year":"2020","journal-title":"Cell Mol. Life Sci. CMLS."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7150\/thno.21089","article-title":"Changes in the microarchitecture of the pancreatic cancer stroma are linked to neutrophil-dependent reprogramming of stellate cells and reflected by diffusion-weighted magnetic resonance imaging","volume":"8","author":"Mayer","year":"2018","journal-title":"Theranostics."},{"issue":"8","key":"10.1016\/j.intimp.2024.112888_b0135","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3390\/biom11081170","article-title":"Neutrophil in the pancreatic tumor microenvironment","volume":"11","author":"Jin","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2024.112888_b0140","doi-asserted-by":"crossref","unstructured":"T. Lianyuan, L. Gang, T. Ming, et al., Tumor associated neutrophils promote the metastasis of pancreatic ductal adenocarcinoma, Cancer Biol. Ther. 21(10):937-945. doi:10.1080\/15384047.2020.1807250.","DOI":"10.1080\/15384047.2020.1807250"},{"issue":"4","key":"10.1016\/j.intimp.2024.112888_b0145","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.apsb.2023.01.020","article-title":"Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis","volume":"13","author":"Chan","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.intimp.2024.112888_b0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ccell.2023.02.001","article-title":"NETworking with cancer: the bidirectional interplay between cancer and neutrophil extracellular traps","volume":"41","author":"Adrover","year":"2023","journal-title":"Cancer Cell"},{"issue":"361","key":"10.1016\/j.intimp.2024.112888_b0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1711","article-title":"Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps","volume":"8","author":"Park","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"18","key":"10.1016\/j.intimp.2024.112888_b0160","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1038\/onc.2016.406","article-title":"Neutrophil extracellular traps: protagonists of cancer progression?","volume":"36","author":"Erpenbeck","year":"2017","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.intimp.2024.112888_b0165","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1158\/0008-5472.CAN-19-0800","article-title":"Neutrophil extracellular traps drive mitochondrial homeostasis in tumors to augment growth","volume":"79","author":"Yazdani","year":"2019","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2024.112888_b0170","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/ATVBAHA.117.309002","article-title":"Neutrophil extracellular traps drive endothelial-to-mesenchymal transition","volume":"37","author":"Pieterse","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0175","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/cgt.2015.21","article-title":"The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer","volume":"22","author":"Boone","year":"2015","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2024.112888_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216155","article-title":"Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice","volume":"562","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.intimp.2024.112888_b0185","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190354","article-title":"Interleukin-17\u2013induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer","volume":"217","author":"Zhang","year":"2020","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.intimp.2024.112888_b0190","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1158\/0008-5472.CAN-20-4125","article-title":"TIMP1 triggers neutrophil extracellular trap formation in pancreatic cancer","volume":"81","author":"Schoeps","year":"2021","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.intimp.2024.112888_b0195","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2024.112888_b0200","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/ijms18030487","article-title":"Pancreatic cancer-induced neutrophil extracellular traps: a potential contributor to cancer-associated thrombosis","volume":"18","author":"Abdol Razak","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2022.101346","article-title":"Mechanisms of thrombosis in pancreatic ductal adenocarcinoma","volume":"35","author":"Campello","year":"2022","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0210","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s12885-018-4584-2","article-title":"Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps","volume":"18","author":"Boone","year":"2018","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2024.112888_b0215","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1605822","article-title":"DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth","volume":"8","author":"Miller-Ocuin","year":"2019","journal-title":"Oncoimmunology."},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0220","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","article-title":"Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma","volume":"145","author":"Ene-Obong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2024.112888_b0225","doi-asserted-by":"crossref","first-page":"1025805","DOI":"10.3389\/fonc.2022.1025805","article-title":"Neutrophils in pancreatic cancer: Potential therapeutic targets","volume":"12","author":"Jiang","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0230","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1245\/s10434-018-6941-4","article-title":"Tumor-infiltrating NETs predict postsurgical survival in patients with pancreatic ductal adenocarcinoma","volume":"26","author":"Jin","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.intimp.2024.112888_b0235","doi-asserted-by":"crossref","first-page":"1027459","DOI":"10.3389\/fimmu.2022.1027459","article-title":"Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.intimp.2024.112888_b0240","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.3390\/cancers14143339","article-title":"Neutrophil extracellular traps and pancreatic cancer development: a vicious cycle","volume":"14","author":"Mitsis","year":"2022","journal-title":"Cancers"},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.112888_b0245","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1007\/s10875-012-9847-0","article-title":"Cancer-related inflammation","volume":"33","author":"Candido","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0250","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0255","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fon.09.136","article-title":"Role of systemic inflammatory response in predicting survival in patients with primary operable cancer","volume":"6","author":"Roxburgh","year":"2010","journal-title":"Future Oncol. Lond. Engl."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0260","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0265","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.intimp.2024.112888_b0270","doi-asserted-by":"crossref","unstructured":"D. shen Wang, H. yan Luo, M. zhen Qiu, et al., Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer, Med. Oncol. Northwood Lond, Engl. 29(5) (2012) 3092-3100. doi:10.1007\/s12032-012-0226-8.","DOI":"10.1007\/s12032-012-0226-8"},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0275","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/03007995.2017.1408579","article-title":"Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?","volume":"34","author":"Dogan","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0280","first-page":"722","article-title":"Significance of the inflammation-based prognostic score in recurrent pancreatic cancer","volume":"19","author":"Nakagawa","year":"2019","journal-title":"Pancreatol off J Int Assoc Pancreatol IAP Al."},{"key":"10.1016\/j.intimp.2024.112888_b0285","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2373868","article-title":"Neutrophil to lymphocyte ratio as a predictor of poor prognosis in metastatic pancreatic cancer patients treated with nab-paclitaxel plus gemcitabine: a propensity score analysis","volume":"2018","author":"Ventriglia","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"issue":"4","key":"10.1016\/j.intimp.2024.112888_b0290","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/ijms18040730","article-title":"The neutrophil\/lymphocyte ratio at diagnosis is significantly associated with survival in metastatic pancreatic cancer patients","volume":"18","author":"Piciucchi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.112888_b0295","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s10147-017-1111-4","article-title":"Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors","volume":"22","author":"Arima","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0300","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0305","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10456-017-9552-y","article-title":"Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?","volume":"20","author":"Ramjiawan","year":"2017","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0310","first-page":"687","article-title":"Tumor angiogenesis and anti-angiogenic gene therapy for cancer","volume":"16","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0315","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-018-0858-1","article-title":"Tumor microenvironment participates in metastasis of pancreatic cancer","volume":"17","author":"Ren","year":"2018","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0320","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.29088","article-title":"Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in mice","volume":"65","author":"Gordon-Weeks","year":"2017","journal-title":"Hepatol Baltim Md."},{"issue":"10","key":"10.1016\/j.intimp.2024.112888_b0325","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.3390\/s18103249","article-title":"Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances","volume":"18","author":"Huang","year":"2018","journal-title":"Sensors"},{"issue":"10","key":"10.1016\/j.intimp.2024.112888_b0330","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat. Cell Biol."},{"issue":"33","key":"10.1016\/j.intimp.2024.112888_b0335","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1073\/pnas.0601807103","article-title":"Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis","volume":"103","author":"Nozawa","year":"2006","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.intimp.2024.112888_b0340","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10456-011-9207-3","article-title":"Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma","volume":"14","author":"Bausch","year":"2011","journal-title":"Angiogenesis"},{"issue":"6669","key":"10.1016\/j.intimp.2024.112888_b0345","doi-asserted-by":"crossref","first-page":"eadf6493","DOI":"10.1126\/science.adf6493","article-title":"Deterministic reprogramming of neutrophils within tumors","volume":"383","author":"Ng","year":"2024","journal-title":"Science."},{"key":"10.1016\/j.intimp.2024.112888_b0350","doi-asserted-by":"crossref","unstructured":"J K, P K, M C, J G, I G, I BB. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer. Int. J. Mol. Sci. 2022;23(4). doi:10.3390\/ijms23042168.","DOI":"10.3390\/ijms23042168"},{"key":"10.1016\/j.intimp.2024.112888_b0355","doi-asserted-by":"crossref","unstructured":"W Z, H W, M S, et al. CXCL5\/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Commun. Lond. Engl. 40(2-3) (2020). doi:10.1002\/cac2.12010.","DOI":"10.1002\/cac2.12010"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0360","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/gutjnl-2020-322744","article-title":"Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism","volume":"71","author":"Sun","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0365","first-page":"62","article-title":"Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1\/2 results in anti-tumor immunity and durable response in pancreatic cancer","volume":"4","author":"Gulhati","year":"2023","journal-title":"Nat. Cancer."},{"key":"10.1016\/j.intimp.2024.112888_b0370","doi-asserted-by":"crossref","unstructured":"Y A, K O, Y O, et al. Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5. PloS One. 2020;15(1). doi:10.1371\/journal.pone.0228015.","DOI":"10.1371\/journal.pone.0228015"},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0375","article-title":"Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis","volume":"241","author":"Mn","year":"2006","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.intimp.2024.112888_b0380","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ajpath.2021.01.002","article-title":"Host Cxcr2-dependent regulation of pancreatic cancer growth, angiogenesis, and metastasis","volume":"191","author":"Purohit","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"22","key":"10.1016\/j.intimp.2024.112888_b0385","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.3390\/ijms20225725","article-title":"Carboxypeptidase E-\u0394N promotes proliferation and invasion of pancreatic cancer cells via upregulation of CXCR2 gene expression","volume":"20","author":"Hareendran","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112888_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216185","article-title":"Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer","volume":"563","author":"Prajapati","year":"2023","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.intimp.2024.112888_b0395","first-page":"5244","article-title":"Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells","volume":"169","author":"Hurst","year":"2002","journal-title":"J. Immunol.Baltim Md 1950"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0400","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/path.5871","article-title":"Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis","volume":"257","author":"Di Maira","year":"2022","journal-title":"J. Pathol."},{"issue":"24","key":"10.1016\/j.intimp.2024.112888_b0405","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.3390\/cancers14246090","article-title":"Activation of OSM-STAT3 epigenetically regulates tumor-promoting transcriptional programs in cervical cancer","volume":"14","author":"Noh","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2024.112888_b0410","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2407-11-125","article-title":"Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines","volume":"11","author":"Fossey","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0415","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/s41467-021-27607-8","article-title":"Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0420","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13402-022-00741-1","article-title":"Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment","volume":"46","author":"Zhu","year":"2023","journal-title":"Cell. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0425","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.trecan.2018.04.001","article-title":"Immunotherapy and prevention of pancreatic cancer","volume":"4","author":"Morrison","year":"2018","journal-title":"Trends Cancer."},{"issue":"10","key":"10.1016\/j.intimp.2024.112888_b0430","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.3390\/curroncol29100541","article-title":"The role of immunotherapy in pancreatic cancer","volume":"29","author":"Mukherji","year":"2022","journal-title":"Curr. Oncol. Tor. Ont."},{"issue":"8","key":"10.1016\/j.intimp.2024.112888_b0435","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.3390\/cancers15082396","article-title":"Cross-dataset single-cell analysis identifies temporal alterations in cell populations of primary pancreatic tumor and liver metastasis","volume":"15","author":"Yang","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0440","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2024.112888_b0445","doi-asserted-by":"crossref","unstructured":"J Z, X Q, H S, et al. Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation. Tumour. Biol. J. Int. Soc. Oncodevelopmental. Biol. Med. 37(4) (2016). doi:10.1007\/s13277-015-4349-3.","DOI":"10.1007\/s13277-015-4349-3"},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0450","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/ijc.28770","article-title":"Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17\u2013a new mechanism of impaired antitumor immunity","volume":"135","author":"Mishalian","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0455","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41467-020-20447-y","article-title":"Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"39","key":"10.1016\/j.intimp.2024.112888_b0460","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004932","article-title":"Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis","volume":"95","author":"Tao","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0465","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cas.15609","article-title":"The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment","volume":"114","author":"Yamamoto","year":"2023","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0470","first-page":"596","article-title":"Neutrophil extracellular traps promote liver micrometastasis in pancreatic ductal adenocarcinoma via the activation of cancer-associated fibroblasts","volume":"56","author":"Takesue","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"22","key":"10.1016\/j.intimp.2024.112888_b0475","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1158\/0008-5472.CAN-22-0968","article-title":"KDM6A loss recruits tumor-associated neutrophils and promotes neutrophil extracellular trap formation in pancreatic cancer","volume":"82","author":"Yang","year":"2022","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0480","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.112888_b0485","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112888_b0490","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.critrevonc.2017.11.010","article-title":"E-cadherin: Its dysregulation in carcinogenesis and clinical implications","volume":"121","author":"Wong","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.intimp.2024.112888_b0495","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/720768","article-title":"Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase","volume":"2012","author":"Grosse-Steffen","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112888_b0500","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1002\/eji.201242628","article-title":"Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors","volume":"42","author":"Gaida","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112888_b0505","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1111\/jcmm.16555","article-title":"Neutrophil extracellular DNA traps promote pancreatic cancer cells migration and invasion by activating EGFR\/ERK pathway","volume":"25","author":"Jin","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0510","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-020-00341-1","article-title":"Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer","volume":"5","author":"Bulle","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.intimp.2024.112888_b0515","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1158\/1541-7786.MCR-20-0860","article-title":"AXL Is a key factor for cell plasticity and promotes metastasis in pancreatic cancer","volume":"19","author":"Du","year":"2021","journal-title":"Mol Cancer Res MCR."},{"issue":"11","key":"10.1016\/j.intimp.2024.112888_b0520","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1136\/gutjnl-2021-325272","article-title":"Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6\/AXL signalling axis","volume":"71","author":"Bellomo","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2024.112888_b0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.10.015","article-title":"Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis","volume":"497","author":"Kajioka","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2024.112888_b0530","doi-asserted-by":"crossref","unstructured":"Am S, G W, R D, et al. Neutrophil extracellular traps drive epithelial-mesenchymal transition of human colon cancer. J. Pathol. 256(4) (2022). doi:10.1002\/path.5860.","DOI":"10.1002\/path.5860"},{"key":"10.1016\/j.intimp.2024.112888_b0535","article-title":"Neutrophil extracellular traps (NETs) promote non-small cell lung cancer metastasis by suppressing lncRNA MIR503HG to activate the NF-\u03baB\/NLRP3 inflammasome pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0540","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7150\/jca.14169","article-title":"Neutrophil granulocytes in ovarian cancer - induction of epithelial-To-Mesenchymal-transition and tumor cell migration","volume":"7","author":"Mayer","year":"2016","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0545","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.3390\/cancers12061542","article-title":"Neutrophil Extracellular Traps (NETs) promote pro-metastatic phenotype in human breast cancer cells through epithelial-mesenchymal transition","volume":"12","author":"Martins-Cardoso","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0550","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.7150\/ijbs.79022","article-title":"Neutrophils promote tumor invasion via FAM3C-mediated epithelial-to-mesenchymal transition in gastric cancer","volume":"19","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0555","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ccr.2014.03.014","article-title":"Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia","volume":"25","author":"McAllister","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.112888_b0560","doi-asserted-by":"crossref","first-page":"5599660","DOI":"10.1155\/2023\/5599660","article-title":"Targeting neutrophil extracellular traps: a novel antitumor strategy","volume":"2023","author":"Zuo","year":"2023","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112888_b0565","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nchembio.1735","article-title":"Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation","volume":"11","author":"Lewis","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"19","key":"10.1016\/j.intimp.2024.112888_b0570","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1158\/0008-5472.CAN-21-4045","article-title":"A novel selective inhibitor JBI-589 targets PAD4-Mediated neutrophil migration to suppress tumor progression","volume":"82","author":"Deng","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0575","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1038\/s41467-018-07306-7","article-title":"Colorectal cancer liver metastatic growth depends on PAD4-driven citrullination of the extracellular matrix","volume":"9","author":"Yuzhalin","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2024.112888_b0580","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1158\/1535-7163.MCT-19-1020","article-title":"A Novel peptidylarginine deiminase 4 (PAD4) inhibitor BMS-P5 blocks formation of neutrophil extracellular traps and delays progression of multiple myeloma","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.intimp.2024.112888_b0585","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/0960327120979028","article-title":"The PAD4 inhibitor GSK484 enhances the radiosensitivity of triple-negative breast cancer","volume":"40","author":"Wei","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112888_b0590","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/cei\/uxad005","article-title":"Chloroquine reduces neutrophil extracellular trap (NET) formation through inhibition of peptidyl arginine deiminase 4 (PAD4)","volume":"211","author":"Ivey","year":"2023","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2024.112888_b0595","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2407-14-375","article-title":"Thrombomodulin expression regulates tumorigenesis in bladder cancer","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0600","first-page":"95","article-title":"Thrombomodulin regulates doxorubicin sensitivity through epithelial-mesenchymal transition in non-small cell lung cancer","volume":"21","author":"Yang","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2024.112888_b0605","doi-asserted-by":"crossref","first-page":"e0160550","DOI":"10.1371\/journal.pone.0160550","article-title":"Thrombomodulin influences the survival of patients with non-metastatic colorectal cancer through epithelial-to-mesenchymal transition (EMT)","volume":"11","author":"Chang","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0610","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1007\/s13277-014-1801-8","article-title":"Thrombomodulin mediates the migratory ability of hormone-independent prostate cancer cells through the regulation of epithelial-to-mesenchymal transition biomarkers","volume":"35","author":"Wu","year":"2014","journal-title":"Tumour. Biol. J. Int. Soc. Oncodevelopmental. Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0615","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13277-013-1005-7","article-title":"Thrombomodulin mediates the migration of cervical cancer cells through the regulation of epithelial-mesenchymal transition biomarkers","volume":"35","author":"Tai","year":"2014","journal-title":"Tumour Biol. J. Int. Soc. Oncodevelopmental. Biol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.112888_b0620","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.3390\/ijms24054896","article-title":"Molecular mechanisms of neutrophil extracellular trap (NETs) degradation","volume":"24","author":"Demkow","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112888_b0625","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jconrel.2023.04.013","article-title":"Cell membrane derived liposomes loaded with DNase I target neutrophil extracellular traps which inhibits colorectal cancer liver metastases","volume":"357","author":"Wang","year":"2023","journal-title":"J. Control Release off J. Control Release Soc."},{"key":"10.1016\/j.intimp.2024.112888_b0630","doi-asserted-by":"crossref","unstructured":"Y X, J H, H Z, et al. AAV-mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response. Mol. Oncol. 14(11) (2020). doi:10.1002\/1878-0261.12787.","DOI":"10.1002\/1878-0261.12787"},{"key":"10.1016\/j.intimp.2024.112888_b0635","doi-asserted-by":"crossref","unstructured":"L. Alekseeva, A. Sen\u2019kova, I. Savin, M. Zenkova, N. Mironova, Human Recombinant DNase I (Pulmozyme\u00ae) Inhibits Lung Metastases in Murine Metastatic B16 Melanoma Model That Correlates with Restoration of the DNase Activity and the Decrease SINE\/LINE and c-Myc Fragments in Blood Cell-Free DNA, Int. J. Mol. Sci. 22(21) (2021) 12074. doi:10.3390\/ijms222112074.","DOI":"10.3390\/ijms222112074"},{"issue":"4","key":"10.1016\/j.intimp.2024.112888_b0640","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ccell.2020.08.015","article-title":"Cholesterol pathway inhibition induces TGF-\u03b2 signaling to promote basal differentiation in pancreatic cancer","volume":"38","author":"Gabitova-Cornell","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.intimp.2024.112888_b0645","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/15548627.2019.1628540","article-title":"TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status","volume":"16","author":"Liang","year":"2020","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0650","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-Induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"issue":"21","key":"10.1016\/j.intimp.2024.112888_b0655","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1038\/s41388-020-1289-1","article-title":"TGF-\u03b21 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation","volume":"39","author":"Cave","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0660","first-page":"315","article-title":"LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer","volume":"41","author":"Cave","year":"2022","journal-title":"J. Exp. Clin. Cancer Res CR."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0665","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.canlet.2016.05.037","article-title":"Combined targeting of TGF-\u03b2, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model","volume":"379","author":"Gore","year":"2016","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.intimp.2024.112888_b0670","first-page":"e2105240","article-title":"Local Release of TGF-\u03b2 inhibitor modulates tumor-associated neutrophils and enhances pancreatic cancer response to combined irreversible electroporation and immunotherapy","volume":"9","author":"Peng","year":"2022","journal-title":"Adv. Sci. Weinh Baden-Wurtt Ger."},{"issue":"24","key":"10.1016\/j.intimp.2024.112888_b0675","article-title":"Sequential targeting TGF-\u03b2 signaling and KRAS Mutation increases therapeutic efficacy in pancreatic cancer","volume":"15","author":"Pei","year":"2019","journal-title":"Small Weinh Bergstr Ger."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0680","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-\u03b2 Signaling in Cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer."},{"issue":"15_suppl","key":"10.1016\/j.intimp.2024.112888_b0685","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1200\/JCO.2016.34.15_suppl.4019","article-title":"A phase II, double-blind study of galunisertib+gemcitabine (GG) vs gemcitabine+placebo (GP) in patients (pts) with unresectable pancreatic cancer (PC)","volume":"34","author":"Melisi","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0690","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1038\/s41467-021-23731-7","article-title":"Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade","volume":"12","author":"Nielsen","year":"2021","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.intimp.2024.112888_b0695","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1073\/pnas.1303302110","article-title":"Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment","volume":"110","author":"Phan","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.112888_b0700","doi-asserted-by":"crossref","first-page":"1170603","DOI":"10.3389\/fimmu.2023.1170603","article-title":"NETosis as an oncologic therapeutic target: a mini review","volume":"14","author":"Jaboury","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112888_b0705","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and chemokine receptors: new targets for cancer immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.intimp.2024.112888_b0710","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.3390\/ijms241713287","article-title":"Bioinformatic analysis of the CXCR2 Ligands in cancer processes","volume":"24","author":"Korbecki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112888_b0715","article-title":"Prognostic biomarkers and immunotherapeutic targets among CXC chemokines in pancreatic adenocarcinoma","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0720","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0725","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/gutjnl-2017-313738","article-title":"Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma","volume":"67","author":"Nywening","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0730","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41389-018-0117-8","article-title":"Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion\/migration and a shift of immune-inflammatory microenvironment","volume":"8","author":"Sano","year":"2019","journal-title":"Oncogenesis."},{"issue":"16","key":"10.1016\/j.intimp.2024.112888_b0735","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.3390\/ijms23169275","article-title":"Senescent human pancreatic stellate cells secrete CXCR2 agonist CXCLs to promote proliferation and migration of human pancreatic cancer AsPC-1 and MIAPaCa-2 cell lines","volume":"23","author":"Takikawa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.intimp.2024.112888_b0740","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1158\/1078-0432.CCR-16-2748","article-title":"Phase Ib Pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2\u2013negative metastatic breast cancer","volume":"23","author":"Schott","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112888_b0745","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2010.11.058","article-title":"Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer","volume":"178","author":"Li","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112888_b0750","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10620-022-07529-1","article-title":"Targeting CXCL5 in pancreatic cancer cells inhibits cancer Xenograft growth by reducing proliferation and inhibiting EMT progression","volume":"68","author":"Wang","year":"2023","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2024.112888_b0755","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic developments in pancreatic cancer: current and future perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0760","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12885-023-11153-1","article-title":"A phase Ib\/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer","volume":"23","author":"Nadal","year":"2023","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2024.112888_b0765","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1470-2045(22)00446-6","article-title":"Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial","volume":"23","author":"Yamazaki","year":"2022","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0770","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13058-019-1243-8","article-title":"A window-of-opportunity trial of the CXCR1\/2 inhibitor reparixin in operable HER-2-negative breast cancer","volume":"22","author":"Goldstein","year":"2020","journal-title":"Breast Cancer Res BCR."},{"key":"10.1016\/j.intimp.2024.112888_b0775","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fcell.2020.00788","article-title":"Tumor-educated neutrophils activate mesenchymal stem cells to promote gastric cancer growth and metastasis","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112888_b0780","first-page":"175","article-title":"Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression","volume":"21","author":"Han","year":"2024","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112888_b0785","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/pcmr.12818","article-title":"Evidence and impact of neutrophil extracellular traps in malignant melanoma","volume":"33","author":"Schedel","year":"2020","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.intimp.2024.112888_b0790","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2019.02.005","article-title":"BCG-induced formation of neutrophil extracellular traps play an important role in bladder cancer treatment","volume":"201","author":"Liu","year":"2019","journal-title":"Clin. Immunol. Orlando Fla."},{"issue":"8","key":"10.1016\/j.intimp.2024.112888_b0795","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1158\/1078-0432.CCR-07-4045","article-title":"Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients","volume":"14","author":"Speetjens","year":"2008","journal-title":"Clin Cancer Res off J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.intimp.2024.112888_b0800","doi-asserted-by":"crossref","unstructured":"M.A. Otten, J.E. Bakema, C.W. Tuk, et al. Enhanced Fc\u03b1RI\u2010mediated neutrophil migration towards tumour colonies in the presence of endothelial cells. doi:10.1002\/eji.201141982.","DOI":"10.1002\/eji.201141982"},{"issue":"7","key":"10.1016\/j.intimp.2024.112888_b0805","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","article-title":"T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants","volume":"186","author":"Hirschhorn","year":"2023","journal-title":"Cell"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924014097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924014097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:09:55Z","timestamp":1786363795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924014097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":161,"alternative-id":["S1567576924014097"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112888","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophils as promising therapeutic targets in pancreatic cancer liver metastasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112888"}}